HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life
science research and clinical diagnostic products, will report financial
results for the third quarter 2018 on Thursday, November 1, 2018,
following the close of the market. The company will discuss these
results in a conference call scheduled for 2 PM Pacific Time (5 PM
Eastern Time) that day.
To listen, call 855-779-9068 within the U.S. or 631-485-4862 outside the
U.S., Conference ID: 5789817. You may also listen to the conference call
live via a webcast that is available on the “Investor Relations” section
of our website under “Quarterly Results” at www.bio-rad.com.
The webcast will be available for up to a year.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in
developing, manufacturing, and marketing a broad range of innovative
products and solutions for the life science research and clinical
diagnostic markets. With a focus on quality and customer service for
over 65 years, our products advance the discovery process and improve
healthcare. Our customers are university and research institutions,
hospitals, public health and commercial laboratories, biotechnology,
pharmaceutical, as well as applied research laboratories that include
food safety and environmental quality testing. Founded in 1952, Bio-Rad
is based in Hercules, California, and has a global network of operations
with more than 8,000 employees worldwide. Bio-Rad had net sales
exceeding $2.1 billion in 2017. For more information, please visit www.bio-rad.com.
Investor & Financial Contacts:
Bio-Rad Laboratories, Inc.
Executive Vice President and Chief Financial
Vice President and Treasurer